LRMR position history
The shares of Larimar Therapeutics (LRMR) that DAFNA Capital Management LLC reported in each quarter’s 13F.
Shares held by quarter
New Add Reduce Exit
- 2021 Q3: 64,487 shares, $744K, 0.20% of portfolio
- 2021 Q4: 70,177 shares, $757K, 0.19% of portfolio, Add +8.8%
- 2022 Q1: 49,996 shares, $202K, 0.05% of portfolio, Reduce −28.8%
- 2022 Q2: 49,996 shares, $98K, 0.03% of portfolio
- 2022 Q3: 574,996 shares, $1.8M, 0.49% of portfolio, Add +1050.1%
- 2022 Q4: 473,136 shares, $2M, 0.55% of portfolio, Reduce −17.7%
- 2023 Q1: 236,873 shares, $1.1M, 0.32% of portfolio, Reduce −49.9%
- 2023 Q2: 350,373 shares, $1.1M, 0.30% of portfolio, Add +47.9%
- 2023 Q3: 327,373 shares, $1.3M, 0.40% of portfolio, Reduce −6.6%
- 2023 Q4: 323,873 shares, $1.5M, 0.35% of portfolio, Reduce −1.1%
- 2024 Q1: 656,373 shares, $5M, 1.1% of portfolio, Add +102.7%
- 2024 Q2: 639,974 shares, $4.6M, 1.1% of portfolio, Reduce −2.5%
- 2024 Q3: 494,274 shares, $3.2M, 0.76% of portfolio, Reduce −22.8%
- 2024 Q4: 371,434 shares, $1.4M, 0.37% of portfolio, Reduce −24.9%
- 2025 Q1: 371,434 shares, $799K, 0.23% of portfolio
- 2025 Q2: 371,434 shares, $1.1M, 0.30% of portfolio
- 2025 Q3: 1,027,764 shares, $3.3M, 0.82% of portfolio, Add +176.7%
- 2025 Q4: 939,164 shares, $3.6M, 0.83% of portfolio, Reduce −8.6%
- 2026 Q1: 2,029,164 shares, $9.1M, 2.1% of portfolio, Add +116.1%
- 2026 Q2: 2,008,164 shares, $6.1M, 1.2% of portfolio, Reduce −1.0%
| Holdings date | Value | % of holdings | Shares | Filing date | All 13F holders |
|---|